Stijn van Rompay
Founder at HYLORIS PHARMACEUTICALS SA
Net worth: 95 M $ as of 2024-03-30
Stijn van Rompay active positions
Companies | Position | Start | End |
---|---|---|---|
HYLORIS PHARMACEUTICALS SA | Director/Board Member | 2020-11-29 | - |
Chief Executive Officer | 2011-12-31 | - | |
Founder | 2011-12-31 | - | |
Director of Finance/CFO | 2020-11-29 | 2021-09-22 | |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Director/Board Member | 2011-12-31 | - |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Director/Board Member | 2019-08-28 | - |
Corporate Officer/Principal | 2019-08-28 | - | |
Chief Executive Officer | 2019-08-28 | - | |
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Part of Novartis AG, Coalesce Product Development Ltd. is a British company that develops inhalation devices. The private company is based in Cambridge, UK. The company was founded in 2009 by Dave Ahern, who has been the CEO since 2009. Coalesce Product Development was acquired by Sandoz AG on March 14, 2022. | Director/Board Member | - | - |
Hyloris Developments SA
Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Hyloris Developments SA is a Belgian pharmaceutical company that manufactures and sells pharmaceutical products. The private company is based in Liege, Belgium. The company was founded in 2013. The CEO is Stijn van Rompay. | Director/Board Member | 2020-04-19 | - |
Chief Executive Officer | 2020-04-19 | - |
Career history of Stijn van Rompay
Former positions of Stijn van Rompay
Companies | Position | Start | End |
---|---|---|---|
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Chief Executive Officer | 2009-12-31 | 2015-07-31 |
Founder | 2009-12-31 | 2015-07-31 | |
Alter Pharma Group NV
Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Alter Pharma Group NV manufactures and distributes pharmaceutical products. The company was founded in 2006 and is headquartered in Anderlecht, Belgium. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Founder | - | - | |
Docpharma NV
Docpharma NV Pharmaceuticals: MajorHealth Technology Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium. | Chief Executive Officer | - | - |
Director of Finance/CFO | - | - |
Training of Stijn van Rompay
University of Antwerp | Graduate Degree |
Statistics
International
Belgium | 9 |
United Kingdom | 2 |
Operational
Chief Executive Officer | 6 |
Director/Board Member | 6 |
Founder | 3 |
Sectoral
Health Technology | 8 |
Consumer Services | 2 |
Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
HYLORIS PHARMACEUTICALS SA | Health Technology |
Private companies | 7 |
---|---|
Docpharma NV
Docpharma NV Pharmaceuticals: MajorHealth Technology Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium. | Health Technology |
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Health Technology |
Alter Pharma Group NV
Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Alter Pharma Group NV manufactures and distributes pharmaceutical products. The company was founded in 2006 and is headquartered in Anderlecht, Belgium. | Health Technology |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Health Technology |
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Part of Novartis AG, Coalesce Product Development Ltd. is a British company that develops inhalation devices. The private company is based in Cambridge, UK. The company was founded in 2009 by Dave Ahern, who has been the CEO since 2009. Coalesce Product Development was acquired by Sandoz AG on March 14, 2022. | Health Technology |
Hyloris Developments SA
Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Hyloris Developments SA is a Belgian pharmaceutical company that manufactures and sells pharmaceutical products. The private company is based in Liege, Belgium. The company was founded in 2013. The CEO is Stijn van Rompay. | Health Technology |
- Stock Market
- Insiders
- Stijn van Rompay
- Experience